药物诱导心肌炎的发展趋势和药物类动态:对20年来药监数据的比较分析
Linping Si1, Haoyang Xiang2,3, Qingyuan Zhang1
1Department of Cardiology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan Shandong China.
Journal of the American Heart Association
|December 3, 2025
概括
药物诱导心肌炎的病例正在增加,特别是使用单克隆抗体和抗精神病药物的病例. 药监测分析显示,特定的高风险群体需要有针对性的监测策略.
科学领域:
- 药监和药物安全 药监和药物安全
- 心血管毒理学心血管毒理学
- 监管科学 监管科学
背景情况:
- 药物诱导的心肌炎是各种药物的日益严重的安全问题.
- 了解时间趋势和识别风险人群对于患者安全至关重要.
研究的目的:
- 用药监督数据分析药物诱导心肌炎的时间趋势.
- 确定与心肌炎相关的高风险患者群体和药物类别.
主要方法:
- 美国食品和药物管理局 (FDA) 的不良事件报告系统 (AERS) 和日本不良药事件报告 (JADER) 数据库 (2004-2023) 的分析.
- 根据治疗类别,识别和分类与心肌炎相关的药物.
- 使用线性回归来评估趋势,按年龄和性别分层.
主要成果:
- 在FDA AERS和JADER数据库中报告的药物诱导心肌炎病例显著增加.
- 单克隆抗体和抗精神病药物被确定为增长最快的风险类别.
- 克洛扎是最常见的药物;趋势因年龄和性别而异,特定药物类别在某些人口统计学群体中发生率更高.
结论:
- 多国药监数据整合有助于早期发现风险.
- 需要精确的监测策略,以针对药物诱导心肌炎的高风险疗法和脆弱人群.
相关概念视频
Therapeutic Drug Monitoring: Overview and Classification
275
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
275
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Myocarditis III: Medical Management
162
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
162
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
Myocarditis I: Introduction
343
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
343
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K


